|
CH495957A
(de)
|
1966-09-15 |
1970-09-15 |
Ceskoslovenska Akademie Ved |
Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
|
|
US3989816A
(en)
|
1975-06-19 |
1976-11-02 |
Nelson Research & Development Company |
Vehicle composition containing 1-substituted azacycloheptan-2-ones
|
|
US4316893A
(en)
|
1975-06-19 |
1982-02-23 |
Nelson Research & Development Co. |
Vehicle composition containing 1-substituted azacycloalkan-2-ones
|
|
US4405616A
(en)
|
1975-06-19 |
1983-09-20 |
Nelson Research & Development Company |
Penetration enhancers for transdermal drug delivery of systemic agents
|
|
GB1548022A
(en)
|
1976-10-06 |
1979-07-04 |
Wyeth John & Brother Ltd |
Pharmaceutial dosage forms
|
|
US4285858A
(en)
|
1979-10-30 |
1981-08-25 |
Mt. Sinai School Of Medicine Of The City University Of N.Y. |
Vasopressin analogs
|
|
US4263283A
(en)
|
1980-05-16 |
1981-04-21 |
Ferring Pharmaceuticals, Inc. |
Method for prophylaxis and/or treatment of sickle cell disease
|
|
GB2111423B
(en)
|
1981-12-02 |
1985-06-26 |
Wyeth John & Brother Ltd |
Making quick-dissolving pills
|
|
DE3275121D1
(en)
|
1981-12-11 |
1987-02-19 |
Wyeth John & Brother Ltd |
Process for preparing solid shaped articles
|
|
US4557934A
(en)
|
1983-06-21 |
1985-12-10 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
|
|
SE8306367L
(sv)
|
1983-11-18 |
1985-05-19 |
Ferring Ab |
Antidiuretiskt verkande farmaceutiskt preparat
|
|
US4863737A
(en)
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
IE60941B1
(en)
|
1986-07-10 |
1994-09-07 |
Elan Transdermal Ltd |
Transdermal drug delivery device
|
|
US4878892A
(en)
|
1987-02-10 |
1989-11-07 |
Drug Delivery Systems Inc. |
Electrolytic transdermal delivery of polypeptides
|
|
US4783450A
(en)
|
1987-04-13 |
1988-11-08 |
Warner-Lambert Company |
Use of commercial lecithin as skin penetration enhancer
|
|
DK365389D0
(da)
|
1989-07-24 |
1989-07-24 |
Fertin Lab As |
Antifungalt tyggegummipraeparat
|
|
US5091186A
(en)
|
1989-08-15 |
1992-02-25 |
Cygnus Therapeutic Systems |
Biphasic transdermal drug delivery device
|
|
TW279133B
(enExample)
|
1990-12-13 |
1996-06-21 |
Elan Med Tech |
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
SE9101022D0
(sv)
|
1991-01-09 |
1991-04-08 |
Paal Svedman |
Medicinsk suganordning
|
|
US6746678B1
(en)
|
1991-02-22 |
2004-06-08 |
Howard K. Shapiro |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
|
|
AU653026B2
(en)
|
1991-06-07 |
1994-09-15 |
Teikoku Seiyaku Kabushiki Kaisha |
Physiologically active polypeptide-containing pharmaceutical composition
|
|
CA2103163C
(en)
|
1991-08-26 |
1998-10-20 |
Mou-Ying Fu Lu |
Compositions and methods for the sublingual or buccal administration of therapeutic agents
|
|
JP2807346B2
(ja)
|
1991-12-24 |
1998-10-08 |
山之内製薬株式会社 |
口腔内崩壊製剤及びその製造法
|
|
US5298256A
(en)
|
1992-04-28 |
1994-03-29 |
Corint, Ltd. |
Desmopressin buccal patch composition
|
|
US5534496A
(en)
|
1992-07-07 |
1996-07-09 |
University Of Southern California |
Methods and compositions to enhance epithelial drug transport
|
|
US5343672A
(en)
|
1992-12-01 |
1994-09-06 |
Scherer Ltd R P |
Method for manufacturing freeze dried dosages in a multilaminate blister pack
|
|
CA2090738C
(en)
|
1993-02-24 |
1996-05-21 |
Hema-Quebec |
Use of paf
|
|
SE9300937L
(sv)
|
1993-03-19 |
1994-09-20 |
Anne Fjellestad Paulsen |
Komposition för oral administrering av peptider
|
|
SE501677C2
(sv)
|
1993-06-18 |
1995-04-10 |
Ferring Bv |
Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
|
|
US5985835A
(en)
|
1993-12-23 |
1999-11-16 |
Ferring B.V. |
Desmopressin for nocturia, incontinence and enuresis
|
|
PT710243E
(pt)
|
1993-06-29 |
2000-11-30 |
Ferring Bv |
Sintese melhorada de peptidos ciclicos.
|
|
US5674850A
(en)
|
1993-12-23 |
1997-10-07 |
Ferring Ab |
High purity desmopressin produced in large single batches
|
|
US5482931A
(en)
|
1993-06-29 |
1996-01-09 |
Ferring Ab |
Stabilized pharmaceutical peptide compositions
|
|
US5500413A
(en)
|
1993-06-29 |
1996-03-19 |
Ferring Ab |
Process for manufacture of 1-deamino-8-D-arginine vasopressin
|
|
CN1101701C
(zh)
|
1993-06-29 |
2003-02-19 |
凡林有限公司 |
由鼻给药的去氨加压素组合物及其制备方法和用途
|
|
JPH09510182A
(ja)
|
1993-11-17 |
1997-10-14 |
エルディーエス・テクノロジーズ・インコーポレーテッド |
カプセル封入されたドラッグデリバリー用透明液
|
|
SE9400918L
(sv)
|
1994-03-18 |
1995-09-19 |
Anne Fjellstad Paulsen |
Stabiliserad komposition för oral administrering av peptider
|
|
US5611806A
(en)
|
1994-05-23 |
1997-03-18 |
Samsung Electro-Mechanics Co., Ltd. |
Skin perforating device for transdermal medication
|
|
SE518619C2
(sv)
|
1994-12-09 |
2002-10-29 |
Gs Dev Ab |
Komposition för reglerad frisättning innehållande monokaproin
|
|
GB9502879D0
(en)
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
|
IL113459A
(en)
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
|
US5843016A
(en)
|
1996-03-18 |
1998-12-01 |
Physion S.R.L. |
Electromotive drug administration for treatment of acute urinary outflow obstruction
|
|
TW411277B
(en)
|
1996-05-13 |
2000-11-11 |
Hisamitsu Pharmaceutical Co |
Percutaneous tape preparation containing fentanyl
|
|
GB9612629D0
(en)
|
1996-06-17 |
1996-08-21 |
Oxford Biosciences Ltd |
Method for providing dense particle compositions for use in transdermal particle delivery
|
|
CA2253549C
(en)
|
1996-06-18 |
2005-10-25 |
Alza Corporation |
Device for enhancing transdermal agent delivery or sampling
|
|
US5763398A
(en)
|
1996-06-20 |
1998-06-09 |
Ferring B.V. |
Nasal administration of desmopressin
|
|
US5922680A
(en)
|
1996-10-23 |
1999-07-13 |
Ferring, B.V. |
Stabilized composition for oral administration of peptides
|
|
SE9604341D0
(sv)
|
1996-11-26 |
1996-11-26 |
Ferring Bv |
Hepta-peptide oxytocin analogue
|
|
FR2758195B1
(fr)
|
1997-01-09 |
1999-02-26 |
Sgs Thomson Microelectronics |
Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
|
|
US5821230A
(en)
|
1997-04-11 |
1998-10-13 |
Ferring Bv |
GnRH antagonist decapeptides
|
|
US5932745A
(en)
|
1997-07-30 |
1999-08-03 |
American Home Products Corporation |
Process for converting propargylic amine-N-oxides to enaminones
|
|
US6511974B1
(en)
|
1997-07-30 |
2003-01-28 |
Wyeth |
Tricyclic vasopressin agonists
|
|
US6194407B1
(en)
|
1997-07-30 |
2001-02-27 |
American Home Products Corporation |
Tricyclic pyrido vasopressin agonists
|
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
|
US7153845B2
(en)
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US20040018241A1
(en)
|
1997-09-26 |
2004-01-29 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
|
US6322532B1
(en)
|
1998-06-24 |
2001-11-27 |
3M Innovative Properties Company |
Sonophoresis method and apparatus
|
|
US7138393B2
(en)
|
1998-07-24 |
2006-11-21 |
Wyeth |
Biologically active vasopressin agonist metabolites
|
|
US6090803A
(en)
|
1998-07-24 |
2000-07-18 |
American Home Products Corporation |
Tricyclic vasopressin agonists
|
|
US6148232A
(en)
|
1998-11-09 |
2000-11-14 |
Elecsys Ltd. |
Transdermal drug delivery and analyte extraction
|
|
GB9827292D0
(en)
|
1998-12-12 |
1999-02-03 |
Univ Strathclyde |
Freeze drying
|
|
US6406455B1
(en)
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
GB9901819D0
(en)
|
1999-01-27 |
1999-03-17 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
US6297234B1
(en)
|
1999-02-04 |
2001-10-02 |
American Home Products Corporation |
Arylthiophene vasopressin agonists
|
|
US6344451B1
(en)
|
1999-02-04 |
2002-02-05 |
American Home Products |
Pyrrolobenzodiazepine carboxyamide vasopressin agonists
|
|
US6235900B1
(en)
|
1999-02-04 |
2001-05-22 |
American Home Products Corporation |
Tricyclic pyridine N-oxides vasopressin agonists
|
|
US6620807B1
(en)
|
1999-02-04 |
2003-09-16 |
Wyeth |
Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
|
|
EP1153616B1
(en)
|
1999-02-15 |
2004-12-01 |
Sumitomo Pharmaceuticals Company, Limited |
Tablets quickly disintegrated in the oral cavity
|
|
DE60031248T2
(de)
|
1999-02-18 |
2007-05-24 |
Biovalve Technologies, Inc., North Grafton |
Elektroaktive pore
|
|
AR014640A1
(es)
|
1999-02-23 |
2001-03-28 |
Univ Nac Quilmes |
UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7060708B2
(en)
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
|
US6210699B1
(en)
|
1999-04-01 |
2001-04-03 |
Watson Pharmaceuticals, Inc. |
Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
|
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
AU7705300A
(en)
|
1999-09-20 |
2001-04-24 |
Ethentica, Inc. |
Trust arbitrage in cryptographic authentication
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
GB2355454A
(en)
|
1999-10-20 |
2001-04-25 |
Ferring Bv |
Antidiuretic agents
|
|
US6558695B2
(en)
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
|
GB0000079D0
(en)
|
2000-01-05 |
2000-02-23 |
Ferring Bv |
Novel antidiuretic agents
|
|
CA2396569C
(en)
|
2000-01-07 |
2010-03-23 |
Biovalve Technologies, Inc. |
Injection device
|
|
US20070032410A1
(en)
|
2000-01-11 |
2007-02-08 |
Atossa Healthcare, Inc. |
Compositions and methods for the treatment of psychiatric disorders
|
|
AT409081B
(de)
|
2000-02-16 |
2002-05-27 |
Gebro Pharma Gmbh |
Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
|
|
GB0015601D0
(en)
|
2000-06-26 |
2000-08-16 |
Ferring Bv |
Novel antidiuretic agents
|
|
US6348486B1
(en)
|
2000-10-17 |
2002-02-19 |
American Home Products Corporation |
Methods for modulating bladder function
|
|
NZ525551A
(en)
|
2000-10-26 |
2005-09-30 |
Alza Corp |
Transdermal drug delivery devices having coated microprotrusions
|
|
US7931614B2
(en)
|
2000-11-30 |
2011-04-26 |
Valeritas, Inc. |
Injection systems
|
|
EP2578252B1
(en)
|
2000-11-30 |
2019-01-09 |
Valeritas, Inc. |
Device with substantially freely movable micro-probe over the housing
|
|
EP1345646A2
(en)
|
2000-12-14 |
2003-09-24 |
Georgia Tech Research Corporation |
Microneedle devices and production thereof
|
|
AU2002231207A1
(en)
|
2000-12-21 |
2002-07-01 |
Biovalve Technologies, Inc. |
Microneedle array systems
|
|
ES2270746T3
(es)
|
2001-03-16 |
2007-12-01 |
Alza Corporation |
Parche transdermico para administrar fentanilo.
|
|
EP1381370B1
(en)
|
2001-04-12 |
2007-03-07 |
Wyeth |
N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
|
|
US7022699B2
(en)
|
2001-04-12 |
2006-04-04 |
Wyeth |
Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
|
|
CN1294134C
(zh)
|
2001-04-12 |
2007-01-10 |
惠氏公司 |
环己基苯基血管升压素激动剂
|
|
GB2391480B
(en)
|
2002-08-05 |
2007-02-28 |
Caretek Medical Ltd |
Drug delivery system
|
|
US7615234B2
(en)
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
|
UA77000C2
(en)
|
2001-09-13 |
2006-10-16 |
Kissei Pharmaceutical |
Crystalline form of hydroxynorephedrine derivative
|
|
US6723077B2
(en)
|
2001-09-28 |
2004-04-20 |
Hewlett-Packard Development Company, L.P. |
Cutaneous administration system
|
|
US6893655B2
(en)
|
2001-10-09 |
2005-05-17 |
3M Innovative Properties Co. |
Transdermal delivery devices
|
|
MY148466A
(en)
|
2001-10-26 |
2013-04-30 |
Merck Frosst Canada Ltd |
Granule formulation
|
|
HUP0402235A2
(hu)
|
2001-11-16 |
2005-02-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
|
|
GB0210397D0
(en)
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
|
HRP20041152B1
(hr)
|
2002-05-07 |
2008-01-31 |
Ferring B.V. |
Farmaceutske formulacije
|
|
WO2003097080A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Sun Pharmaceutical Industries Limited |
A stable aqueous composition of a peptide
|
|
US6945952B2
(en)
|
2002-06-25 |
2005-09-20 |
Theraject, Inc. |
Solid solution perforator for drug delivery and other applications
|
|
EP1590033A2
(en)
|
2002-09-30 |
2005-11-02 |
Alza Corporation |
Drug delivery device having coated microprojections incorporating vasoconstrictors
|
|
BR0314754A
(pt)
|
2002-10-09 |
2005-07-26 |
Toray Industries |
Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
|
|
US7383084B2
(en)
|
2002-10-31 |
2008-06-03 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
|
EP1428526A1
(en)
|
2002-12-13 |
2004-06-16 |
Rijksuniversiteit Groningen |
Formulation for fast dissolution of lipophilic compounds
|
|
DE10259934B3
(de)
|
2002-12-20 |
2004-10-14 |
H.C. Starck Gmbh |
Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
|
|
AR042815A1
(es)
|
2002-12-26 |
2005-07-06 |
Alza Corp |
Dispositivo de suministro de agente activo que tiene miembros compuestos
|
|
SI1619185T1
(sl)
|
2003-04-28 |
2011-09-30 |
Astellas Pharma Inc |
4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol
|
|
US20060193825A1
(en)
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US7094545B2
(en)
|
2003-04-30 |
2006-08-22 |
Ferring Bv |
Pharmaceutical composition as solid dosage form and method for manufacturing thereof
|
|
PL1638468T3
(pl)
|
2003-06-30 |
2008-01-31 |
Alza Corp |
Sposób powlekania mikrowystępów do przekłuwania skóry
|
|
ATE301990T1
(de)
|
2003-07-25 |
2005-09-15 |
Ferring Bv |
Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
|
|
CN1826099B
(zh)
|
2003-07-25 |
2010-06-09 |
凡林有限公司 |
固体剂型药物组合物及其制造方法
|
|
US6930932B2
(en)
|
2003-08-27 |
2005-08-16 |
Hewlett-Packard Development Company, L.P. |
Data signal reception latch control using clock aligned relative to strobe signal
|
|
BRPI0415466A
(pt)
|
2003-10-24 |
2006-12-19 |
Alza Corp |
método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos
|
|
AU2004285481A1
(en)
|
2003-10-24 |
2005-05-12 |
Alza Corporation |
Apparatus and method for enhancing transdermal drug delivery
|
|
ES2377647T3
(es)
|
2003-10-31 |
2012-03-29 |
Alza Corporation |
Aplicador auto-actuado para ordenamiento de microproyecciones
|
|
EP2322195A2
(en)
*
|
2003-11-10 |
2011-05-18 |
Reprise Biopharmaceutics, LLC |
Pharmaceutical compositions including low dosages of desmopressin
|
|
EP1530967B1
(en)
|
2003-11-13 |
2006-05-03 |
Ferring B.V. |
Blister pack and solid dosage form comprising desmopressin
|
|
FR2862230B1
(fr)
|
2003-11-17 |
2005-12-16 |
Rossignol Sa |
Fixation de surf
|
|
US7018653B2
(en)
|
2003-12-29 |
2006-03-28 |
Ferring B.V. |
Method for preparing solid dosage form of desmopressin
|
|
EP1550439B1
(en)
|
2003-12-29 |
2006-03-08 |
Ferring B.V. |
Method for preparing a solid dosage form of desmopressin
|
|
JP2007519446A
(ja)
|
2004-01-09 |
2007-07-19 |
アルザ・コーポレーシヨン |
振動支援型の経皮的な薬剤の送達法および系
|
|
GB0406048D0
(en)
*
|
2004-03-18 |
2004-04-21 |
Ardana Bioscience Ltd |
Drug formulations
|
|
HRP20160455T1
(hr)
|
2004-09-09 |
2016-07-15 |
Yeda Research And Development Co., Ltd. |
Smjese polipeptida, sastavi koji ih sadrže i postupci za njihovu pripremu, te njihove primjene
|
|
US7097776B2
(en)
|
2004-10-22 |
2006-08-29 |
Hewlett-Packard Development Company, L.P. |
Method of fabricating microneedles
|
|
US20060093658A1
(en)
|
2004-10-26 |
2006-05-04 |
Gayatri Sathyan |
Apparatus and method for transdermal delivery of desmopressin
|
|
CN100339081C
(zh)
|
2004-11-10 |
2007-09-26 |
范敏华 |
一种氯雷他定口腔崩解片剂的制备方法
|
|
US20080009801A1
(en)
|
2004-12-02 |
2008-01-10 |
Nickel Janice H |
Method for dispensing material into a drug delivery device
|
|
US7180274B2
(en)
|
2004-12-10 |
2007-02-20 |
Aimtron Technology Corp. |
Switching voltage regulator operating without a discontinuous mode
|
|
AU2006239942A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Dihydrobenzofuran derivatives and uses thereof
|
|
WO2006116165A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Chromane and chromene derivatives and uses thereof
|
|
CA2605580A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzodioxane and benzodioxolane derivatives and uses thereof
|
|
US7368477B2
(en)
|
2005-04-22 |
2008-05-06 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof
|
|
TW200718692A
(en)
|
2005-04-22 |
2007-05-16 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
|
US7856263B2
(en)
|
2005-04-22 |
2010-12-21 |
Travanti Pharma Inc. |
Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
|
|
US20060258712A1
(en)
|
2005-04-24 |
2006-11-16 |
Wyeth |
Methods for modulating bladder function
|
|
WO2006138719A2
(en)
|
2005-06-17 |
2006-12-28 |
Georgia Tech Research Corporation |
Coated microstructures and method of manufacture thereof
|
|
EP1904158B1
(en)
|
2005-06-24 |
2013-07-24 |
3M Innovative Properties Company |
Collapsible patch with microneedle array
|
|
WO2007021970A2
(en)
|
2005-08-15 |
2007-02-22 |
Praecis Pharmaceuticals, Inc. |
Stable pharmaceutical formulations and methods of use thereof
|
|
WO2007083323A2
(en)
|
2006-01-23 |
2007-07-26 |
Panacea Biotec Limited. |
Modified release oral dosage form comprising desmopressin
|
|
CA2584456C
(en)
|
2006-03-02 |
2008-07-22 |
Ferring International Center S.A. |
Composition comprising desmopressin
|
|
WO2007127976A2
(en)
|
2006-05-01 |
2007-11-08 |
Georgia Tech Research Corporation |
Particle based molding
|
|
AU2008283929B2
(en)
|
2007-08-06 |
2013-10-10 |
Serenity Pharmaceuticals, Llc |
Methods and devices for desmopressin drug delivery
|
|
US20100286045A1
(en)
|
2008-05-21 |
2010-11-11 |
Bjarke Mirner Klein |
Methods comprising desmopressin
|
|
PL2712622T3
(pl)
|
2008-05-21 |
2017-01-31 |
Ferring B.V. |
Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
|
|
JP5151774B2
(ja)
|
2008-07-29 |
2013-02-27 |
株式会社リコー |
クリーニング装置、プロセスユニット及び画像形成装置
|
|
US20150306170A1
(en)
|
2012-11-21 |
2015-10-29 |
Ferring B.V. |
Composition for immediate and extended release
|